Precision medicine section

Click to go to next article

Click to scroll back to the top

Click to go to previous article

Research & Education News for Houston Methodist

result

Precision Medicine

Houston Methodist Researchers Generate and Validate Humanized Biomimetic Nanovesicles to Target Neurons – Two Firsts in Nanovesicle Theranostics

In a paper recently published in Advanced Science, Houston Methodist researchers successfully targeted human neurons in vitro with humanized biomimetic nanovesicles in an effort to improve specificity of neuro theranostics.

Q & A session with Dr. Carly Filgueira

Q & A session with Carly Filgueira, PhD, assistant professor in the Departments of Nanomedicine and Cardiovascular Surgery at Houston Methodist.

Biomimetic nano drug delivery carriers for treating cardiovascular diseases

Inspired by our own cells, biomimetic nano-carrier platforms may one day improve the safety and efficacy of cardiovascular disease medications by improving interactions with target cells and extending circulation times.

RNA therapeutics have the potential to transform standard patient care and actualize personalized medicine

RNA as a therapeutic molecule holds great power and the potential to alter the standard of care for patients, actualize personalized medicine, and have diverse applications.

The power of nanotechnology to manipulate theranostics and technology in cardiovascular disease management

Nanotechnology offers a steadily climbing number of applications and advances in the treatment and prevention of cardiovascular diseases - the leading cause of death in the United States

New theranostic shows promise for treating triple-negative breast cancer

The radiolabeled ⁶⁴Cu/¹⁷⁷Lu-DOTA-diZD small synthetic molecule revolutionizes treatment strategies for primary and metastatic tumors in aggressive triple-negative breast cancer by targeting angiogenic receptors.

Interleukin 9 secreting polarized T cells show potential in solid and liquid tumor treatment

A cancer patient’s T cells, engineered to carry a receptor found on the surface of malignant cells, can aggressively attack tumors - with the potential to revolutionize solid tumor treatment.

Carfilzomib therapy may enhance longevity in lung transplant recipients

Carfilzomib therapy shows potential in improving patient outcomes and longevity.

Predicting Efficacy of Anti-cancer Immunotherapies

Math model enables more personalized cancer treatment

New high-throughput analytic enables differentiation of tumor cells within its microenvironment

Experts from the Center for Bioinformatics and Computational Biology have devised a new technology

Valve Mimics Body's Mechanics

Stephen Little, MD, designs a realistic mitral valve

Rethinking the Unthinkable

Tackling dementia with multi-modal imaging and precision medicine

Viewing the Future in 360°

Texas’ first Surgical Theater debuts in neurosurgery

Nano Doses Delivered in Space

Study explores potential biomedical applications at the ISS

Sign up for our monthly newsletter

Follow us

Copyright 2021. Houston Methodist, Houston, TX. All rights reserved.

Privacy & Disclaimer

Sign Up for Our Monthly Newsletter

Browse the Archive